Dupuytren’s contracture is a condition that affects the connective tissue in the palm known as palmar fascia. Auxilium Pharma estimates that approximately 13% of the European population is affected by Dupuytren’s contracture."
Tuesday, March 1, 2011
EU Approval for Xiapex - Yahoo! Finance
EU Approval for Xiapex - Yahoo! Finance: "Pfizer(NYSE: PFE - News) and Auxilium Pharmaceuticals, Inc. (NasdaqGS: AUXL - News) recently announced that the European Commission has granted marketing authorization to Xiapex for the treatment of Dupuytren's contracture in adult patients with a palpable cord.
Dupuytren’s contracture is a condition that affects the connective tissue in the palm known as palmar fascia. Auxilium Pharma estimates that approximately 13% of the European population is affected by Dupuytren’s contracture."
Dupuytren’s contracture is a condition that affects the connective tissue in the palm known as palmar fascia. Auxilium Pharma estimates that approximately 13% of the European population is affected by Dupuytren’s contracture."
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment